Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2007
11/21/2007EP1525223B1 Ox40 (=cd134) receptor agonists and therapeutic use
11/21/2007EP1523313B1 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4- 1-(pyridin-2-ylmethyl)piperidin-4-yl -1h-indol-3-yl -1h-pyrrole mono-hydrochloride
11/21/2007EP1482920B1 Compositions containing n-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
11/21/2007EP1414492B1 Method for treating multiple myeloma
11/21/2007EP1301500B1 Nitrosated and nitrosylated taxanes, compositions and methods of use
11/21/2007EP1281711B1 Interstrand crosslinking agents for dna and compounds therefor
11/21/2007EP1269196B1 Method of screening for inhibitors of osteopontin
11/21/2007EP1263958B1 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
11/21/2007EP1200459B1 Compounds for treatment of infectious and immune system disorders and methods for their use
11/21/2007EP1187919B1 Recombinant adenoviruses encoding the sodium/iodide symporter (nis)
11/21/2007EP1019087B1 Ganglioside immunostimulating complexes and uses thereof
11/21/2007CN101076371A Novel pharmaceutical composition containing at least one dolastatin 10 derivative
11/21/2007CN101076336A Novel curcumin analogues and uses thereof
11/21/2007CN101076325A Medicinal composition of edible carboxylic-acid and/or its acid salts and caffeine and non-drug addiction coffee
11/21/2007CN101074267A Transduced peptide-humanized granular leukocyte macrophage colony stimulating factor fusion protein and its medicinal composition
11/21/2007CN101074266A Transduced peptide-humanized granular leukocyte colony stimulating factor fusion protein and its medicinal composition
11/21/2007CN101074261A TRAIL receptor I and/or TRAIL receptor 2 specific antibody and its use
11/21/2007CN101074255A Preparation of hemsleyadine-A and its use of preparing pharmaceutics against cancers
11/21/2007CN101074254A Sequence against human esophagus cancer invasion and transfer
11/21/2007CN101074234A Antitumor antibiotics and its production
11/21/2007CN101074229A 7-azaindirubin and 7-azaisoindigo derivative, its production and pharmaceutical use
11/21/2007CN101074227A Phosphine acyloxy quinazoline derivatives and their medicine using
11/21/2007CN101074218A Cephalotamannine derivative, its production, its medicinal composition and use
11/21/2007CN101074215A Production of 1-[3,5-2(2,2-dimethyl) ethylcyano] benzyl triazole
11/21/2007CN101074210A Pharmaceutically active isoindoline derivatives
11/21/2007CN101074202A Production of injecting reductive glutathione
11/21/2007CN101074189A Styrene acid derivative and use in preparation of various blood-vessels target agent medicine
11/21/2007CN101073668A Antibody compositions for selectively inhibiting vegf
11/21/2007CN101073667A Enhancer for antibody to lymphocytic tumors
11/21/2007CN101073665A Use of lymphotoxin in treatment of medicine for increasing chemoradiotherapeutic sensitivity
11/21/2007CN101073664A Uso of W-peptide in treatment of tumor
11/21/2007CN101073663A Chinese-medicinal composition for treating malignant tumor and its production
11/21/2007CN101073643A Chinese-medicinal preparation for preventing and treating alactasia and gynecopathy, its production and use
11/21/2007CN101073636A Compound Chinese herb medicinal preparation for treating tumors
11/21/2007CN101073611A Medicinal composition for preventing tumor
11/21/2007CN101073599A Total tanshinone and total phenolic acid extract in red-rooted salvia root and its production
11/21/2007CN101073583A Use of red nocardial cell wall skeleton in preparation of medicine
11/21/2007CN101073578A Tubematricoside B in preparation of medicine for preventing angiogenesis, tumor invasion and transfer
11/21/2007CN101073564A Medicinal composition containing L-glutamine
11/21/2007CN101073561A Use of compound with structure similia combretastatin A4 in preparation medicine for inhibiting tubulin polymerization or treating tumor
11/21/2007CN101073554A Anti-cancer composition containing tyrosine kinase inhibitor and alkylating agent
11/21/2007CN101073429A Zanghonghua Chinese-medicinal beverage
11/21/2007CN101073427A Glossy ganoderma cordycepin beverage and its production
11/21/2007CN101073411A Cactus health-care beverage for tumour patient
11/21/2007CN101073409A Multipurpose medicinal edible food
11/21/2007CN100350047C Human growth colyone receptor 2 subtgpe and E.coli cytosine deaminizing enzyme co-expression vector and its establishing and use
11/21/2007CN100349920C Ganalioside-associated recombinant antibodies and use thereof in diagnosis and treatment of tumours
11/21/2007CN100349919C Monoclonal antibody and its preparing process and usage
11/21/2007CN100349913C 2'-fluoronucleosides
11/21/2007CN100349899C Catechol sodium complex and its prepn and application in medicine for preventing and treating cancer and tumor
11/21/2007CN100349898C Podophyllotoxin derivatives and their preparing method
11/21/2007CN100349888C Medicine compound
11/21/2007CN100349887C Substituted 4-aryl-4H-pyrrolo[2,3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/21/2007CN100349874C Novel compounds
11/21/2007CN100349862C 大麻素受体配体 Cannabinoid receptor ligands
11/21/2007CN100349627C Medical devices containing rapamycin analogs
11/21/2007CN100349585C Dampness dispersing, cancer resisting medicine, its preparation method and its application in the process for preparing anticancer medicine
11/21/2007CN100349582C Oil seed bruceae lyophilized powder for injection and its preparing method
11/21/2007CN100349581C Traditional Chinese medicine for treating cancer and tumor and all kinds of inflammatory disease
11/21/2007CN100349571C Transdermal therapeutic system containing testosterone and method for the production thereof
11/21/2007CN100349570C 10-hydoxy camptothecin self micro emulsifieation composition
11/21/2007CN100349565C Curcumenol solid lipid nano-particle and its preparation method
11/20/2007US7297818 Adamantane derivatives
11/20/2007US7297792 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
11/20/2007US7297779 An oligonucleotide that inhibits the function or expression of Asef (APC-stimulated guanine nucleotide exchange factor)
11/20/2007US7297774 Isolated or purified mutated human fibroblast growth factor receptor-4 (FGFR-4) comprising point mutation resulting in replacement of glycine with arginine; tyrosine kinase inhibitors; anticarcinogenic agents
11/20/2007US7297703 Macrolides
11/20/2007US7297701 Anti-cancer cyclopenta [G]quinazoline compounds
11/20/2007US7297698 e.g. (2R,5S)-4-(3-chloro-4-cyanophenyl)-N-(2-cyclopropylpyrimidin-5-yl)-2,5-dimethylpiperazine-1-carboxamide; antiandrogenic agent
11/20/2007US7297695 Anticancer agents; inhibits tyrosine kinase activity of growth factor receptors; antiproliferative agents
11/20/2007US7297694 central nervous system disorders; traumas; anticancer agents; neurodegenerative agents; analgesics; headaches and cardiovascular disorders
11/20/2007US7297693 furan-, pyrrole- or thiophenecarboxamides ring-substituted with a hydroxyimino-fused ring and a nitrogen heteroarene; e.g., 5-[5-(1-Morpholin-4-yl-methanoyl)-2-pyridin-4-yl-furan-3-yl]-indan-1-one oxime;treating neurotraumatic diseases, cancer, neurodegeneration, pain, migraine and cardiac hypertrophy
11/20/2007US7297692 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
11/20/2007US7297684 breast and prostatic tumors; administration of an antisense oligodeoxynucleotide which is complementary to a portion of the gene encoding insulin-like growth factor binding protein -5
11/20/2007US7297681 For use in therapy of growth metabolic disorders
11/20/2007US7297523 Human elongase genes and uses thereof
11/20/2007US7297334 Anti-vegf antibodies
11/20/2007US7297330 Low dose haptenized tumor cell and tumor cell extract immunotherapy
11/20/2007CA2344652C Carboxymethylgalactose derivatives
11/20/2007CA2262409C Modified tie-2-receptor ligands
11/20/2007CA2260926C Illudin analogs useful as antitumor agents
11/20/2007CA2171743C Nucleotide analogs
11/20/2007CA2140382C Vitamin d compounds and method of preparing these compounds
11/15/2007WO2007131034A1 Pyrimidone derivatives which are modulators of heat shock protein (hsp) 70
11/15/2007WO2007130783A2 Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates
11/15/2007WO2007130404A1 Methods of using [3.2.0] heterocyclic compounds and analogs thereof for the treatment of lung cancer
11/15/2007WO2007129646A1 Macrolide derivative
11/15/2007WO2007129457A1 Therapeutic agents for alzheimer's disease and cancer
11/15/2007WO2007129066A1 4- (2,6-dichloro-benzoylamino) -1h-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl) -amide for the treatment of cancer
11/15/2007WO2007129062A1 Pharmaceutical combinations of diazole derivatives for cancer treatment
11/15/2007WO2007129052A1 Pyrazole derivatives and their use as pi3k inhibitors
11/15/2007WO2007129048A1 Thiazole derivatives as inhibitors of p13 kinase
11/15/2007WO2007129044A1 Thiazole derivatives and their use as anti-tumour agents
11/15/2007WO2007129020A1 Pyrimidine derivatives useful as dhfr inhibitors
11/15/2007WO2007129019A1 Sulfonamide compounds useful as edg receptor modulators
11/15/2007WO2007129005A1 Aminoacid derivatives of thiazoles as inhibitors of pi3 kinase
11/15/2007WO2007128987A2 Therapy targeting cathepsin s
11/15/2007WO2007128968A1 Telomerase inhibitors
11/15/2007WO2007128829A2 18,21-didesoxymacbecin derivatives for the treatment of cancer
11/15/2007WO2007128820A1 Combination comprising an iron chelator and an anti-neoplastic agent and use thereof
1 ... 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 ... 2211